1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 55 and over Sponsor: Other Protocol IDs: LAL-07OLD, NCT01366898
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 40 and over Sponsor: Other Protocol IDs: ASAPOL, NCT01549418
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: PZ-1001-403-NS, NCT01621451
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000577892, SINGAPORE-ICR-02, SINGAPORE-ASCOLT, SINGAPORE-07-32-LGI, ICR-02, NCT00565708
|
|
5.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 to 85 Sponsor: Other Protocol IDs: 2010-018360-16, NCT01058902
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MPD-RC 112, P01CA108671, NCT01259856
|
|
7.
|
Phase: Phase III Type: Prevention Status: Approved-not yet active Age: 40 to 60 Sponsor: Other Protocol IDs: CREAT, NCT01496521
|
|
8.
|
Phase: Phase III Type: Prevention Status: Active Age: 55 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: TIPS-3, NCT01646437
|
|
9.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HEMMYL0018, AR_MM_PI_007, SU-05062011-7711, NCT01355705
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: UCI 07-47, NCT00578721
|
|
11.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention Status: Active Age: 40 to 120 Sponsor: NCI Protocol IDs: NCI-2009-01192, R01CA113681, MC054A, NCT00983580
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: VICC BMT 1020, NCT01215344
|
|
13.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MPD-RC 111, P01CA108671, NCT01259817
|
|
14.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RV-MM-PI-0345, NCT01380106
|
|
15.
|
Phase: Phase II Type: Treatment Status: Active Age: 50 to 80 Sponsor: Other Protocol IDs: ChineseAMS CH-BC-011, NCT01431053
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: INHANSE-ASPOD, ASPOD, EU-21083, ASPOD, ISRCTN-31503555, EU-21083, NCT01238185
|
|
17.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: V1010, NCT01612247
|